Thioredoxin 1 epitope and monoclonal antibody specifically binding thereto
US-2024248090-A1 · Jul 25, 2024 · US
US10422790B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10422790-B2 |
| Application number | US-201715853503-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 22, 2017 |
| Priority date | Mar 30, 2012 |
| Publication date | Sep 24, 2019 |
| Grant date | Sep 24, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A problem to be solved by the present invention is to provide an immunochromatographic test strip and a detection method using immunochromatography avoiding aggregation of colloidal gold conjugates while red blood cells in whole blood are agglutinated and then separated and removed in the case of using polybrene as a blood-agglutinating agent and the colloidal gold conjugates as a detection reagent. To solve the problem, the present inventors reviewed a past reagent configuration itself from a completely different viewpoint rather than selecting type and amount of polyanions and, as a result of extensive study on each element, the inventors surprisingly found that aggregation of colloidal gold can be suppressed by using a certain buffer solution without using neutralization by polyanions.
Opening claim text (preview).
The invention claimed is: 1. An immunochromatographic test strip comprising: (1) a membrane comprising a porous body, which comprises a sample-supply portion and a spreading portion, wherein the sample-supply portion is upstream from the spreading portion, wherein the sample-supply portion contains hexadimethrine bromide, wherein a conjugate of an anti-analyte antibody labeled with colloidal gold is retained in a dissoluble manner in a conjugate-retaining part of the spreading portion, and an antibody is immobilized in a detecting part of the spreading portion, which is downstream from the conjugate-retaining part; and (2) a buffer solution component in a dry state, wherein the buffer solution component is contained in the conjugate-retaining part of the spreading portion so as to be able to contact with hexadimethrine bromide provided through the sample-supply portion, and wherein the buffer solution component is selected from a group consisting of Bis-Tris, MES, and citric acid, wherein the test strip does not comprise a polyanion as a neutralizer for neutralizing a cation of the hexadimethrine bromide. 2. The test strip of claim 1 , wherein the sample-supply portion contains the buffer solution component. 3. The test strip of claim 1 , wherein Bis-Tris and MES are at pH lower than pKa. 4. The test strip of claim 1 , wherein the conjugate-retaining part is a conjugate pad. 5. The test strip of claim 4 , wherein the sample-supply portion is a sample pad.
Test strips · CPC title
Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding · CPC title
involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025) · CPC title
Apparatus specially adapted for solid-phase testing · CPC title
Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.